Tag: CBT > Business Issues/ Benchmarks > Finance: Page 12

Finance

TerrAscend Announces Amendment of Pennsylvania Credit Agreement

The amendment will reduce the company’s debt by $35 million and annual interest expense by $5 million.

December 21, 2022

Finance

Green Thumb Appoints New Board Member, 4 Executive Leadership Positions

The cannabis company’s expanded leadership team will take effect Jan. 1, roughly three months after three board members resigned.

December 13, 2022

Finance

TerrAscend Appoints Seasoned Finance Professional to Board

Ira Duarte joins the company’s board of directors with more than 25 years of experience in finance, accounting and auditing leadership roles.

December 2, 2022

Finance

TerrAscend Reduces Outstanding Debt by US$30 Million

The company elected to pay down $30 million of its maturing $55 million senior secured Michigan loan, refinancing the remaining $25 million.

December 1, 2022

Finance

Shryne Group Names Gregory Fink as Chief Financial Officer

Fink, who previously worked at comScore and Fannie Mae, is responsible for streamlining operations to maximize Shryne Group's profitability.

November 30, 2022

Finance

Ascend Wellness Files Registration Statement; Has Option to Issue $100M of New Securities

The multistate cannabis operator’s filing on Form C-3 contains a base shelf prospectus with the U.S. Securities and Exchange.

November 23, 2022

Finance

California Cannabis Sales Hit 9-Quarter Low

The world’s largest legal market has also experienced declining tax revenues for five straight quarters.

November 21, 2022

Finance

Verano Announces 3Q 2022 Financial Results

The company’s third quarter 2022 revenue increased 2% versus the prior quarter and 10% year-over-year to $228 million.

November 14, 2022

Finance

Will Biden’s Order to Review Cannabis’s CSA Scheduling Impact Publicly Traded Cannabis Companies?

Cannabis experts and publicly traded operators weigh in on the announcement’s effects on stocks last month, as well what the future could hold if cannabis is either descheduled or rescheduled from its current Schedule I status in the Controlled Substances Act.

November 1, 2022

Finance

Canopy Growth Faces Possible Delisting From Nasdaq Upon US Entrance

Company officials stated there is no assurance that Nasdaq will harmonize its general policies with SEC’s accounting guidance.

November 1, 2022

Finance

SEC Charges Canadian Cannabis Company, Former Senior Executive With Accounting Fraud

The SEC officials found the company violated the antifraud, reporting, books and records, and internal controls provisions of the federal securities laws.

October 25, 2022

Finance

Flower One’s Canadian Parent Company Has Filed for Restructuring Proceedings

Understood as the Canadian version of the U.S. bankruptcy process, Flower One Holdings’ latest move suggests significant financial problems.

October 20, 2022